Eduardo Rene Salas
CIK 1924188 · last filed 2026-02-11
Eduardo Rene Salas is a corporate insider who has filed 9 SEC Form 4 insider transactions across 2 companies since 2022. The most recent filing, for ADMA, was dated Feb 11, 2026. Current disclosed insider exposure totals $177.2K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$177.2K
2
9
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ADMA | Director | 21,579 | $8.21 | $177.2K | $0 | 3 | 2026-02-11 |
| Intra-Cellular Therapies, Inc. (ITCI) Delisted | Director | 0 | $131.87 | $0 | $0 | 6 | 2025-04-02 |
Recent Filings
9 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-11 | ADMA | Grant (A) | +10,690 | $0 | EDGAR |
| 2025-04-02 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Disp (D) | −1,567 | -$206.8K | EDGAR |
| 2025-02-21 | ADMA | Grant (A) | +10,889 | $0 | EDGAR |
| 2025-01-02 | ADMA | Grant (A) | — | $0 | EDGAR |
| 2024-06-25 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Exer (M) | +1,567 | $0 | EDGAR |
| 2024-06-18 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-27 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-13 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-04-21 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Grant (A) | — | $0 | EDGAR |